Arkolith/Insider Trading/AVEO/Form 4

New Enterprise Associates 15, L.P.

10% OwnerAVEO PHARMACEUTICALS, INC. (AVEO) · full profile →Form 4 · filed Oct 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 19, 2022Other(J)4.0M—$00
Oct 19, 2022Other(J)4.0M—$00
Oct 19, 2022Other(J)4.0M—$04.0M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-054286) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML